David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DISCK
301
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $49.7M | 0.08% |
1,686,594
-713,406
| -30% | -$21.6M |
|
302
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
| $49.7M | 0.08% |
110,000
-45,300
| -29% | -$19.2M |
|
|
303
CALL
IBM
IBM
$222B
| $49.6M | 0.08% |
323,528
+234,618
| +264% | +$35.6M |
|
|
MDVN
304
DELISTED
MEDIVATION, INC.
MDVN
| $49.4M | 0.08% |
765,140
-712,204
| -48% | -$40.8M |
|
|
MRSH
305
Marsh
MRSH
$91.6B
| $49.3M | 0.08% |
879,677
-41,048
| -4% | -$2.31M |
|
|
FLIR
306
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $49.2M | 0.08% |
1,573,789
+211,007
| +15% | +$6.65M |
|
307
Herbalife
HLF
$1.33B
| $49.2M | 0.08% |
2,300,418
+148,278
| +7% | +$2.53M |
|
308
CVS Health
CVS
$119B
| $49M | 0.08% |
474,681
-85,164
| -15% | -$8.62M |
|
|
LO
309
DELISTED
LORILLARD INC COM STK
LO
| $49M | 0.08% |
749,298
+379,044
| +102% | +$25.2M |
|
|
WBA
310
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $48.9M | 0.07% |
577,700
-106,600
| -16% | -$8.49M |
|
311
Bath & Body Works
BBWI
$3.92B
| $48.8M | 0.07% |
640,465
+541,897
| +550% | +$39.1M |
|
312
PUT
McDonald's
MCD
$192B
| $48.7M | 0.07% |
500,000
-532,700
| -52% | -$50.5M |
|
|
XLNX
313
DELISTED
Xilinx Inc
XLNX
| $48.6M | 0.07% |
1,147,895
+955,697
| +497% | +$39.2M |
|
|
TMUSP
314
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $48.6M | 0.07% |
825,000
+75,000
| +10% | +$4.37M |
|
315
PUT
Boeing
BA
$169B
| $48.3M | 0.07% |
322,000
-272,500
| -46% | -$39.7M |
|
316
SLM Corp
SLM
$4.97B
| $48.3M | 0.07% |
5,203,530
-1,513,653
| -23% | -$14.2M |
|
317
Outfront Media
OUT
$5.25B
| $48.1M | 0.07% |
1,634,452
-383,401
| -19% | -$10.9M |
|
318
Alibaba
BABA
$286B
| $47.6M | 0.07% |
571,334
+491,330
| +614% | +$44.3M |
|
|
WCN
319
Waste Connections
WCN
$42.6B
| $47.3M | 0.07% |
1,474,062
+349,032
| +31% | +$10.7M |
|
320
Owens Corning
OC
$11.7B
| $47.2M | 0.07% |
1,087,936
-199,826
| -16% | -$7.92M |
|
321
News Corp Class A
NWSA
$16.4B
| $47.2M | 0.07% |
2,948,037
-1,311,585
| -31% | -$21.2M |
|
322
Ecolab
ECL
$78.9B
| $46.8M | 0.07% |
409,073
+28,288
| +7% | +$3.1M |
|
|
APC
323
CALL
DELISTED
Anadarko Petroleum
APC
| $46.8M | 0.07% |
564,700
+58,800
| +12% | +$4.81M |
|
324
CALL
Micron Technology
MU
$1.09T
| $46.5M | 0.07% |
1,713,100
-1,968,800
| -53% | -$58.8M |
|
|
AGN
325
CALL
DELISTED
Allergan plc
AGN
| $46.3M | 0.07% |
155,436
+48,536
| +45% | +$13.8M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.